Molecular Testing Improves Nodular Fasciitis Diagnosis - Summary - MDSpire

Molecular Testing Improves Nodular Fasciitis Diagnosis

USP6 analysis helps resolve uncertainty in atypical soft-tissue lesions

  • By

  • Andrea Surnit

  • April 3, 2026

  • 3 min

Share

Objective:

To evaluate the effectiveness of molecular testing in diagnosing nodular fasciitis, particularly in cases with non-specific presentations.

Approach:
    Key Findings:
    • Molecular testing identified USP6 rearrangements in all clinically non-specific cases of nodular fasciitis.
    • 66% of cases did not initially raise clinical suspicion for nodular fasciitis.
    • Fluorescence in situ hybridization detected rearrangements in 83% of tested cases.
    • Next-generation sequencing resolved inconclusive cases and identified rare fusion partners.
    Interpretation:

    Molecular diagnostics significantly enhance the diagnostic accuracy for nodular fasciitis, especially in atypical presentations that mimic aggressive tumors.

    Limitations:
    • Small sample size.
    • Single-institution, retrospective design.
    Conclusion:

    Molecular testing can improve diagnostic confidence for pathologists and aid in recognizing nodular fasciitis in challenging cases.

    Sources:

Original Source(s)

Molecular Testing Improves Nodular Fasciitis Diagnosis

  • by Andrea Surnit

  • April 3, 2026

Related Content

DNA Quality Outweighs Bone Source

Background DNA burden was more strongly associated with sequencing profile completeness than bone source in unidentified human remains.

Handwriting Kinematics Differentiate Cognitive Impairment

“Diagnostic differentiation emerged only under tasks imposing higher cognitive-motor demands.”

Do Head Hits Shift the Gut Microbiome?

A small observational study in collegiate football players found microbiome associations after nonconcussive head impacts, though findings were limited by severe underpowering and high attrition